Qingji Xu, PhD
he/him/his
Postdoctoral AssociateDownloadHi-Res Photo
About
Titles
Postdoctoral Associate
Appointments
Education & Training
- PhD
- Institute of Biophysics, Chinese Academy of Sciences, Cell Biology (2023)
- BS
- College of Life Sciences, Jilin University, Biopharmaceutical Engineering (2017)
Research
Overview
Medical Research Interests
Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Immunotherapy; Melanoma; Molecular Targeted Therapy
ORCID
0000-0002-9524-1848Yan Lab@Yale
Cancer Epigenetics and Stem Cell Biology
View Lab Website
Research at a Glance
Publications Timeline
A big-picture view of Qingji Xu's research output by year.
4Publications
Publications
2023
CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway.
Chen J, Xu Q, Liu D, Li X, Guo M, Chen X, Liao J, Lei R, Li W, Huang H, Saw PE, Song E, Yan X, Nie Y. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway. Cancer Commun (Lond) 2023, 43: 1244-1266. PMID: 37856423, DOI: 10.1002/cac2.12495.Peer-Reviewed Original Research
2021
Structure basis for AA98 inhibition on the activation of endothelial cells mediated by CD146.
Chen X, Yan H, Liu D, Xu Q, Duan H, Feng J, Yan X, Xie C. Structure basis for AA98 inhibition on the activation of endothelial cells mediated by CD146. IScience 2021, 24: 102417. PMID: 33997697, DOI: 10.1016/j.isci.2021.102417.Peer-Reviewed Original Research
2020
CD146, from a melanoma cell adhesion molecule to a signaling receptor.
Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther 2020, 5: 148. PMID: 32782280, DOI: 10.1038/s41392-020-00259-8.Peer-Reviewed Original Research
2018
CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-β signaling-induced epithelial-mesenchymal transition.
Ma Y, Zhang H, Xiong C, Liu Z, Xu Q, Feng J, Zhang J, Wang Z, Yan X. CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-β signaling-induced epithelial-mesenchymal transition. Cancer Lett 2018, 430: 201-214. PMID: 29777784, DOI: 10.1016/j.canlet.2018.05.016.Peer-Reviewed Original Research
Get In Touch
Contacts
Email
Locations
Lauder Hall
Lab
310 Cedar Street, Fl 3, Rm 304
New Haven, CT 06510